Evidence map›Paper›PMID 23659472›Full record

ArticleBiochemistry2013

Reversal of the substrate specificity of CMP N-glycosidase to dCMP.

Megan D Sikowitz, Lisa E Cooper, Tadhg P Begley, Pierre Alexandre Kaminski, Steven E Ealick

Abstract read
In one paragraph

Article in Biochemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Frontiers in bioengineering and biotechnology · 2020
    Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Megan D SikowitzDepartment of Chemistry and Chemical Biology, Cornell University, Ithaca, NY 14853, USA.
Lisa E Cooper
Tadhg P Begley
Pierre Alexandre Kaminski
Steven E Ealick
Cornell University · USTexas A&M University · USInstitut Pasteur · FR

Funding

Overall EvaluationP41GM103403 · NIGMS · CORNELL UNIVERSITY · PI EALICK, STEVEN E · 2012 to 2017
$14.3M
CHEMISTRY OF BIOLOGICAL SYSTEMST32GM008500 · NIGMS · CORNELL UNIVERSITY ITHACA · PI LIN, HENING · 1996 to 2020
$5.4M
Structural Biology of Purine and Pyrimidine Biosynthesis and MetabolismR01GM073220 · NIGMS · CORNELL UNIVERSITY ITHACA · PI EALICK, STEVEN E · 2005 to 2012
$2.4M
NIGMS NIH HHS GM103403NIGMS NIH HHS GM73220NIGMS NIH HHS P41 GM103403NIGMS NIH HHS R01 GM073220NIGMS NIH HHS T32 GM008500NIGMS NIH HHS T32GM008500
6 · The paper itself

Abstract

MilB is a CMP hydrolase involved in the early steps of biosynthesis of the antifungal compound mildiomycin. An enzyme from the bacimethrin biosynthetic pathway, BcmB, is closely related to MilB in both sequence and function. These two enzymes belong to the nucleoside 2'-deoxyribosyltransferase (NDT) superfamily. NDTs catalyze N-glycosidic bond cleavage of 2'-deoxynucleosides via a covalent 2-deoxyribosyl-enzyme intermediate. Conservation of key active site residues suggests that members of the NDT superfamily share a common mechanism; however, the enzymes differ in their substrate preferences. Substrates vary in the type of nucleobase, the presence or absence of a 2'-hydroxyl group, and the presence or absence of a 5'-phosphate group. We have determined the structures of MilB and BcmB and compared them to previously determined structures of NDT superfamily members. The comparisons reveal how these enzymes differentiate between ribosyl and deoxyribosyl nucleotides or nucleosides and among different nucleobases. The 1.6 Å structure of the MilB-CMP complex reveals an active site feature that is not obvious from comparisons of sequence alone. MilB and BcmB that prefer substrates containing 2'-ribosyl groups have a phenylalanine positioned in the active site, whereas NDT family members with a preference for 2'-deoxyribosyl groups have a tyrosine residue. Further studies show that the phenylalanine is critical for the specificity of MilB and BcmB toward CMP, and mutation of this phenylalanine residue to tyrosine results in a 1000-fold reversal of substrate specificity from CMP to dCMP.

Indexed as

Amino Acid SubstitutionBacterial ProteinsCatalytic DomainClostridium botulinum type ACrystallography, X-RayDeoxycytidine MonophosphateKineticsModels, MolecularMutagenesis, Site-DirectedPentosyltransferasesProtein Structure, SecondaryStreptomycesStructural Homology, ProteinSubstrate SpecificityBacterial ProteinsDeoxycytidine Monophosphatenucleoside deoxyribosyltransferasePentosyltransferases

Identifiers

PMID23659472
PMCPMC3750073
OpenAlexW2047037491

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.